28 news items
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
BMY
23 May 24
materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
BMY
16 May 24
and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
BMY
15 May 24
cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
BMY
10 May 24
results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
AAL
AAPL
ABBV
29 Apr 24
. On the other hand, healthcare, energy, and materials have reported year-over-year earnings declines.
See Also
5pqss2wvvtvfo2urt6ms4b67e
BMY
26 Apr 24
and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements
vjr22mq glm9dqwtdoy786gg4710sea0svieft41fqru82z6f4un019
BMY
CVX
META
26 Apr 24
, health care and real estate stocks recording the biggest losses on Thursday. However, materials and emergy stocks bucked the overall market trend
sq3e17vep3gu4gko2t2suj7ycp979dh61okq
BMY
25 Apr 24
be confusing to investors. These items are uncertain, depend on various factors and may have a material impact on our future GAAP results. See
ccu28 758urvt2rg5
BMY
6 Apr 24
control and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied
crmo562sxj4uqjr6r hoogayg48v30glancpc49rpzhjs45mvgth19kt
BMY
TSVT
5 Apr 24
and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements
8llr 299p3istpuaj67
BMY
2 Apr 24
our control and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied
dcjjpm78mvo071s6ecta6134tcbqrnle9eofe31k3v4tb6gmq
BMY
2 Apr 24
materiality
c57wmou7esxsmcmgun9cw8qcehdzj7e2pln89jd9m97ah23qjed3cx015n
BMY
CATX
LNTH
28 Mar 24
to differ materially from the results described in or implied by the forward-looking statements, including, without limitation: the Company's ability
2sugyqz313cwca1jdwpfy9 uvhtswjm3tgsmv
BMY
25 Mar 24
materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others
htx7b3qb4jjm4atns90jv
BMY
20 Mar 24
and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements